Geode Capital Management
HCAT icon

Geode Capital Management’s Health Catalyst HCAT Stock Holding History

Geode Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Sell
891,357
-610,076
-41% -$881K ﹤0.01% 3219
2026
Q1 		$1.91M Sell
1,501,433
-167,046
-10% -$314K ﹤0.01% 3144
2025
Q4 		$3.99M Sell
1,668,479
-70,425
-4% -$193K ﹤0.01% 2889
2025
Q3 		$4.96M Buy
1,738,904
+76,449
+5% +$262K ﹤0.01% 2783
2025
Q2 		$6.27M Buy
1,662,455
+169,580
+11% +$667K ﹤0.01% 2614
2025
Q1 		$6.76M Buy
1,492,875
+46,275
+3% +$245K ﹤0.01% 2512
2024
Q4 		$10.2M Buy
1,446,600
+3,564
+0.2% +$28.4K ﹤0.01% 2357
2024
Q3 		$11.7M Buy
1,443,036
+66,896
+5% +$483K ﹤0.01% 2288
2024
Q2 		$8.8M Buy
1,376,140
+56,968
+4% +$366K ﹤0.01% 2401
2024
Q1 		$9.93M Buy
1,319,172
+58,504
+5% +$534K ﹤0.01% 2332
2023
Q4 		$11.7M Buy
1,260,668
+80,058
+7% +$654K ﹤0.01% 2243
2023
Q3 		$11.9M Buy
1,180,610
+50,870
+5% +$607K ﹤0.01% 2152
2023
Q2 		$14.1M Buy
1,129,740
+48,489
+4% +$577K ﹤0.01% 2083
2023
Q1 		$12.6M Buy
1,081,251
+33,302
+3% +$425K ﹤0.01% 2108
2022
Q4 		$11.1M Buy
1,047,949
+13,842
+1% +$134K ﹤0.01% 2197
2022
Q3 		$10M Sell
1,034,107
-60,955
-6% -$807K ﹤0.01% 2255
2022
Q2 		$15.9M Buy
1,095,062
+111,550
+11% +$1.9M ﹤0.01% 1932
2022
Q1 		$25.7M Buy
983,512
+65,651
+7% +$1.86M ﹤0.01% 1714
2021
Q4 		$36.4M Buy
917,861
+56,966
+7% +$2.6M ﹤0.01% 1545
2021
Q3 		$43.1M Buy
860,895
+191,007
+29% +$10.4M 0.01% 1402
2021
Q2 		$37.2M Buy
669,888
+107,574
+19% +$5.73M 0.01% 1550
2021
Q1 		$26.3M Buy
562,314
+32,879
+6% +$1.59M ﹤0.01% 1700
2020
Q4 		$23M Buy
529,435
+42,866
+9% +$1.58M ﹤0.01% 1633
2020
Q3 		$17.8M Buy
486,569
+191,648
+65% +$6.51M ﹤0.01% 1610
2020
Q2 		$8.6M Buy
294,921
+93,720
+47% +$2.59M ﹤0.01% 2012
2020
Q1 		$5.26M Buy
201,201
+99,312
+97% +$3.03M ﹤0.01% 2118
2019
Q4 		$3.54M Buy
101,889
+9,352
+10% +$310K ﹤0.01% 2658
2019
Q3 		$2.93M Buy
+92,537
New +$3.64M ﹤0.01% 2703

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HWM
HighMark Wealth Management St. Paul, Minnesota $299M AUM 53.01% 1-Year Est. Return

Geode Capital Management's HCAT Position: Q2 2026 in Review

Geode Capital Management reduced its Health Catalyst (HCAT) stake by 41% in Q2 2026, selling an estimated $881K and leaving 891,357 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #3219.

Geode Capital Management first reported a position in HCAT in Q3 2019 and has held it in 28 quarters since. The position peaked at $43.1M in Q3 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Geode Capital Management held 891,357 shares of Health Catalyst worth $1.77M as of Q2 2026.
  • Geode Capital Management sold 610,076 Health Catalyst shares in Q2 2026, an estimated $881K.
  • Health Catalyst made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3219 holding.
  • Geode Capital Management first reported a position in Health Catalyst in Q3 2019 and has held it in 28 quarters since.
  • Geode Capital Management's Health Catalyst position peaked at $43.1M in Q3 2021.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.